Immobilization of nicotinic acetylcholine receptors in mouse C2 myotubes by agrin-induced protein tyrosine phosphorylation by unknown
Immobilization of Nicotinic Acetylcholine Receptors inMouse C2 
Myotubes by Agrin-induced Protein Tyrosine Phosphorylation 
Thomas Meier, Gail M. Perez, and Bruce G. Wallace 
Department of Physiology, University of Colorado Health Sciences Center, Denver, Colorado 80262 
Abstract. Agrin induces the formation of highly local- 
ized specializations on myotubes at which nicotinic ace- 
tylcholine receptors (AChRs) and many other compo- 
nents of the postsynaptic apparatus at the vertebrate 
skeletal neuromuscular  junction accumulate. Agrin also 
induces AChR tyrosine phosphorylation. Treatments 
that inhibit tyrosine phosphorylation prevent AChR 
aggregation. To examine further the relationship be- 
tween tyrosine phosphorylation and receptor aggrega- 
tion, we have used the technique of fluorescence recov- 
ery after photobleaching to assess the lateral mobility 
of AChRs and other surface proteins in mouse C2 myo- 
tubes treated with agrin or with pervanadate, a protein 
tyrosine phosphatase inhibitor. Agrin induced the for- 
mation of patches in C2 myotubes that stained in- 
tensely with anti-phosphotyrosine antibodies and 
within which AChRs were relatively immobile. Pervan- 
adate, on the other hand, increased protein tyrosine 
phosphorylation throughout the myotube and caused a 
reduction in the mobility of diffusely distributed 
AChRs, without affecting the mobility of other mem- 
brane proteins. Pervanadate, like agrin, caused an in- 
crease in AChR tyrosine phosphorylation and a de- 
crease in the rate at which AChRs could be extracted 
from intact myotubes by mild detergent treatment, sug- 
gesting that immobilized receptors were phosphory- 
lated and therefore less extractable. Indeed, phospho- 
rylated receptors were extracted from agrin-treated 
myotubes more slowly than nonphosphorylated recep- 
tors. AChR aggregates at developing neuromuscular 
junctions in embryonic rat muscles also labeled with 
anti-phosphotyrosine antibodies, suggesting that ty- 
rosine phosphorylation could mediate AChR aggrega- 
tion in vivo as well. Thus, agrin appears to induce 
AChR aggregation by creating circumscribed domains 
of increased protein tyrosine phosphorylation within 
which receptors become phosphorylated and immobi- 
lized. 
F 
ORMATION of the vertebrate skeletal neuromuscular 
junction involves  the localized  accumulation of a 
variety of cytoplasmic,  membrane, and extracellu- 
lar matrix-associated proteins in the postsynaptic muscle 
cell.  The  accumulation of several  such  components, in- 
cluding  the nicotinic  acetylcholine receptor (AChR)  1, is 
induced by the protein agrin (McMahan, 1990; Reist et al., 
1992), apparently by binding to a receptor on the muscle 
cell surface  (Nitkin et al., 1987). Recent experiments on 
chick myotubes in culture demonstrate that agrin activates 
a protein tyrosine kinase, causing a rapid increase in ty- 
rosine phosphorylation of the AChR ~3 subunit and a de- 
crease in the rate at which AChRs are extracted from in- 
tact myotubes by mild detergent treatment (Wallace et al., 
1991; Wallace, 1994, 1995). Inhibitors of agrin-induced ty- 
rosine  phosphorylation  prevent  the  agrin-induced  de- 
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1. Abbreviations used in this paper. AChR, nicotinic acetylcholine recep- 
tor; sConA, succinyl-Con A; TCA, trichloroacetic acid. 
crease in AChR detergent extractability and block AChR 
aggregation.  These and other findings suggest that agrin- 
induced protein tyrosine phosphorylation strengthens the 
interaction of AChRs with the cytoskeleton and that this 
process plays a role in the formation of AChR aggregates 
(Wallace, 1995). 
A characteristic feature of agrin-induced AChR aggre- 
gation is that it is highly localized. AChR aggregates form 
selectively at sites where myotubes come into contact with 
cells or surfaces coated with agrin (Campanelli et al., 1991; 
Tsim et al., 1992; Ferns et al., 1992, 1993), or with agrin on 
axon terminals or in basal lamina (McMahan and Slater, 
1984; Cohen and Godfrey, 1992; Reist et al., 1992; Cohen 
et al., 1995). This suggests that if increases  in protein ty- 
rosine phosphorylation induced by the interaction of agrin 
with its receptor play a role in AChR aggregation,  then 
such increases  are likely to be confined to the vicinity of 
the activated agrin receptor. 
The aim of the experiments reported here was to under- 
stand how agrin-induced changes in tyrosine phosphoryla- 
tion  and  AChR  detergent  extractability could  lead  to 
AChR aggregation.  A simple explanation for the forma- 
tion of AChR aggregates  would be a modification of the 
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Frisch (1976).  According to this scheme, if agrin-induced 
increases  in  protein  tyrosine  phosphorylation  and  de- 
creases in AChR detergent extractability resulted in im- 
mobilization of AChRs and if such changes were restricted 
to certain regions of the myotube, then AChRs, which are 
normally free to diffuse laterally in the plane of the mem- 
brane, would gradually accumulate within such regions, 
creating receptor aggregates. Myotubes appear to have a 
relatively small number of receptors  for agrin scattered 
over their surface (Nastuk et al., 1991). At developing neu- 
romuscular junctions, contact with agrin is restricted to the 
synaptic site, and so AChR aggregation would occur there. 
When agrin is added to the medium bathing myotubes in 
culture,  as in the  experiments reported  here,  each acti- 
vated agrin receptor might stimulate protein tyrosine ki- 
nases  in  its  immediate  vicinity,  thereby  creating  small 
patches scattered over the myotube surface within which 
AChRs would accumulate (Wallace, 1995). 
To test the hypothesis that agrin creates regions of in- 
creased tyrosine phosphorylation which act  as traps  for 
AChRs,  we  have  examined changes  in  AChR  tyrosine 
phosphorylation, lateral mobility, and detergent extract- 
ability. The mobility of AChRs and other proteins on the 
surface of cultured mouse C2 myotubes was measured us- 
ing  the  technique  of  fluorescence  recovery  after  pho- 
tobleaching (Axelrod et al., 1976; Dubinsky et al., 1989). 
This technique has been used previously to demonstrate 
that  most  randomly distributed  receptors  are  relatively 
free to diffuse laterally in the lipid bilayer, while within ag- 
gregates most AChRs are relatively immobile. We found 
that  in  C2  myotubes  agrin  induced  the  formation  of 
patches of increased tyrosine phosphorylation within which 
AChRs were relatively immobile. On the other hand, per- 
vanadate,  an  inhibitor of protein  tyrosine phosphatases 
(Pumiglia et al., 1992), caused an increase in tyrosine phos- 
phorylation and a decrease in AChR mobility throughout 
the myotube. Both agrin  and pervanadate  caused a  de- 
crease in the rate at which AChRs were extracted from in- 
tact C2 myotubes by mild detergent treatment, as previ- 
ously reported  for  chick  myotubes  (Wallace,  1995).  In 
agrin-treated C2 myotubes phosphorylated receptors were 
extracted more slowly than nonphosphorylated receptors. 
These observations are consistent with the hypothesis that 
agrin induces the formation of domains of increased ty- 
rosine phosphorylation within which AChRs become phos- 
phorylated and immobilized as a consequence of interacting 
more strongly with the cytoskeleton. Preliminary accounts 
of some of these results have been published previously 
(Perez,  G.  M., T.  Meier,  and B.  G. Wallace.  1994. Soc. 
Neurosci. Abstr. 20:867). 
Materials and Methods 
C2C12 Mouse Cell Line 
C2C12 cells (Yaffe and Saxel, 1977; Blau et al., 1983) were grown in DME 
(GIBCO BRL, Gaithersburg, MD) containing 20% FBS (GIBCO BRL), 
0.5% chick embryo extract, 2 mM glutamine, 100 U/ml penicillin and 100 
~g/ml streptomycin (Gemini Products, Calabasas, CA) on 35-mm tissue- 
culture dishes (Gordon and Hall, 19891. As the cells approached conflu- 
ence, the cultures were changed to fusion medium, consisting of DME- 
high glucose (Sigma Chemical Co., St. Louis, MO) supplemented with 5% 
horse serum (GIBCO BRL), glutamine and antibiotics, to induce differ- 
entiation. Cultures were used after 4-6 d in fusion medium, by which time 
cells had fused to form myotubes. For detergent extraction experiments 
cells were grown on collagen-coated dishes. During incubations with agrin 
or pervanadate, the medium was changed to DME-F12 (Sigma Chemical 
Co.) supplemented with 0.8 mM CaC12, 1 mg/ml bovine serum albumin 
(RIA Grade, Sigma Chemical Co.), 20 ixg/ml conalbumin (type II; Sigma 
Chemical Co.), glutamine and antibiotics (Wallace, 1989). 
Agrin and Pervanadate 
Experiments were carded out with a saturating dose (4U) of partially pu- 
rified agrin (Cibacron pool) prepared from electric organ of Torpedo cali- 
fornica as previously described (Nitkin et al., 1987). In most experiments 
cultures were treated with agrin for 4  h, by which time agrin-induced 
changes in AChR aggregation, phosphorytation, and detergent extract- 
ability had reached a  maximum. Sodium pervanadate was prepared by 
adding 1 part of 500 mM H202 to 50 parts of 10 mM sodium orthovana- 
date (Sigma Chemical Co.) in modified Tyrodes solution, incubating the 
mixture for 10 min at room temperature, and diluting it into defined me- 
dium immediately before use (Pumiglia et al., 1992; Wallace, 1995). Cul- 
tures were routinely treated with 30 ~M pervanadate for 1 h, which pro- 
duced a maximal response. 
Quantitation  of  A ChR Aggregation 
C2 myotubes were labeled with 2 ×  10 -8 M rhodamine-conjugated ct-bun- 
garotoxin (Molecular Probes, Eugene, OR), rinsed, and fixed as described 
for chick myotubes (Wallace 1989, 1992). For each culture, AChR aggre- 
gates on 10 myotubes were counted by eye with a 40x objective on a Ni- 
kon Optiphot microscope equipped for phase and fluorescence micros- 
copy. 
Immunohistochemistry 
C2 myotubes were labeled with rhodamine-conjugated c~-bungarotoxin  as 
described above, rinsed with PBS, fixed, and permeabilized for 5 min with 
-20°C 95% ethanol, rinsed with Tris buffered saline (TBS), incubated 1 h 
with 1:1,000 anti-phosphotyrosine mAb PY20 (ICN ImmunoBiologicals, 
Costa Mesa, CA) in TBS containing 0.05% Triton X-100 (TBS-T), rinsed 
in TBS, incubated 1 h  with 1:200 fluorescein (DTAF)-conjugated goat 
anti-mouse IgG (Jackson ImmunoResearch Labs, West Grove, PA  /  in 
TBS-T containing 10% normal goat serum, rinsed, dehydrated, and mounted 
in AF1  (Citifluor, Ltd., London). No staining was observed with anti- 
phosphotyrosine antibodies unless myotubes were first permeabilized, in- 
dicating  that  the  phosphotyrosine-containing proteins  were  predomi- 
nately intracellular. 
Diaphragms were removed from El8 rat embryos, rinsed in PBS, fixed 
in 1% paraformaldehyde dissolved in 90 mM sodium phosphate, pH 7.2, 
containing 160 mM sucrose, rinsed with TBS containing 0.5% Triton X-100 
(TBS-TI')  and incubated 1 h  in anti-phosphotyrosine monoclonal anti- 
body PY20 or mAb 4G10  (Upstate Biotechnology Incorporated, Lake 
Placid, NY) diluted 1:2,000 in TBS-TI'. The tissue was washed 3 ×  10 min 
in TBS-Tr, incubated 1 h in 1:300 fluorescein-conjugated  goat anti-mouse 
IgG in TBS-TT containing 3% BSA, 10%  normal goat serum and 2  × 
10 -6 M rhodamine-conjugated a-bungarotoxin, rinsed 4  ×  15 min TBS- 
TT, and mounted in Citifluor AF1. 
Measurement of A ChR Phosphorylation 
C2 cultures were rinsed with minimum essential medium without sodium 
phosphate (GIBCO BRL) supplemented with 1 mg/ml bovine serum al- 
bumin (RIA grade, Sigma Chemical Co.), 20 p~g/ml conalbumin (type II, 
Sigma Chemical Co.), 100 U/ml penicillin, and 100 ixg/ml streptomycin, 
followed by a 4- or 16-h incubation in the same medium containing 0.5 
mCi/ml [32p]orthophosphate ([32p]H3PO 4 in H20, ICN Biomedicals Inc.). 
A 4-h incubation was sufficient to label phosphoproteins to steady state 
levels. Biotinylated a-bungarotoxin (4 ×  10 -s M, Molecular Probes, Inc.) 
was added for the final hour of incubation to label AChRs (Wallace et al., 
1991).  After washing the cultures in ice-cold phosphate buffered saline 
containing 1 mM phenylmethylsulfonyl fluoride, toxin-AChR complexes 
were solubilized by incubating each culture for 10 min on ice in extraction 
buffer (20 mM sodium phosphate buffer, pH 7.4,  supplemented with 5 
mM EDTA, 5 mM EGTA, 50 mM sodium fluoride, 40 mM sodium pyro- 
phosphate, 10 mM sodium molybdate, 1 mM sodium orthovanadate, 5 p~g/ 
ml aprotinin, 5 p~g/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride and 
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and the supernatants incubated 2 h  at 4°C with 2.5 I~1 streptavidin-conju- 
gated agarose beads (Molecular Probes, Inc.). The beads were washed 
with 2 x  1 mi extraction buffer, 2 x  1 ml extraction buffer supplemented 
with 1 M sodium chloride, and 1 x  1 ml buffer containing 50 mM sodium 
phosphate, 50 mM sodium chloride, 1 mM sodium orthovanadate, pH 7.4. 
After washing the beads, AChRs were eluted into SDS sample buffer at 
room temperature and subjected to electrophoresis on 7.5%  SDS-poly- 
acrylamide gels (Laemmli, 1970).  Gels were fixed, dried, and exposed to 
preflashed autoradiography film (Hyperfilm-MP, Amersham, Arlington 
Heights, IL). Nonspecific binding was determined by adding 2 x  10 -6 M 
c~-bungarotoxin during incubation with biotin-conjugated toxin. 
AChR 13, 7, and ~ subunits were tentatively identified by their positions 
relative to prestained molecular weight markers (Sigma Chemical Co.). 
The apparent molecular weights of the AChR subunits (13 ~50 kD, 7 ~58 
kD, 8 ~63 kD) were similar to those reported for AChRs isolated from 
C2 myotubes by Gu et al. (1989), although doublets of the ~ and ~ sub- 
units, arising from partial proteolysis, were not observed. We confirmed 
the identity of the AChR 13 subunit on Western blots using mAb 148, 
which is specific for the AChR 13 subunit (Tzartos et al., 1993). The appar- 
ent lack of partially degraded subunits in our 32p-labeled extracts may re- 
sult from isolating surface AChRs selectively or from other differences in 
the isolation protocol. (We cannot rule out the possibility that the peptide 
we designate as the ~/subunit is actually a partially degraded 8 subunit, 
and that the 7 subunit is missing  entirely. The ~ and particularly the ~ sub- 
units are known to be susceptible to proteolysis and have often been diffi- 
cult to detect in muscle cells [Merlie and Sebbane, 1981; Gu et al., 1989; 
Forsayeth et al., 1990]. However, we found that our putative ~/and 8 sub- 
units had different phosphopeptide maps, consistent with their being two 
distinct subunits.) Autoradiograms were analyzed by densitometry as pre- 
viously described (Wallace, 1994).  " 
Assays for Protein SerinelThreonine and 
Tyrosine Phosphorylation 
To measure protein serine/threonine phosphorylation, cultures were la- 
beled with 10 i~Ci/ml  [32p]orthophosphate, rinsed, and extracted as de- 
scribed above for AChR isolation. Soluble proteins were precipitated with 
10% trichloroacetic acid (TCA) and the radioactivity associated with the 
acetone-washed  precipitates  determined  by  Cerenkov  counting.  Since 
phosphoserine  and  phosphothreonine  typically  account  for  >99%  of 
phosphoamino acids in proteins  in cell  extracts  (Cooper  et  al.,  1983), 
changes in the incorporation of radiolabeled phosphate into TCA precipi- 
tates  provides  a  measure of protein  serine/threonine phosphorylation. 
Protein tyrosine phosphorylation was measured by dot blot analysis using 
affinity-purified rabbit  polyclonal anti-phosphotyrosine antibodies from 
rabbits immunized with phosphotyrosine-conjugated bovine serum albu- 
min (Ohtsuka et al., 1984).  Cultures were extracted as described for isola- 
tion of AChRs and aliquots of the extracts were applied to nitrocellulose. 
The blots were probed with anti-phosphotyrosine antibodies and the ECL 
detection system (Amersham Corp.) as previously described (Wallace et 
al., 1991; Wallace, 1995), and analyzed by densitometry. 
Phosphoamino Acid Analysis 
Regions containing individual 32p-labeled AChR subunits were excised 
from dried gels after autoradiography, the gel slices rehydrated, and pro- 
teins extracted and hydrolyzed in 5.8 N HCI at 110°C for 90 rain according 
to standard protocols (Boyle et al., 1991; van der Geer and Hunter, 1994). 
Phosphoamino acids were dissolved in pH 1.9 buffer and separated in one 
dimension by thin layer chromatography (TLC) on Merck 0.l-ram cellu- 
lose plates (EM Separations, Gibbstown, N J) in isobutyric acid:n-butanol: 
acetic acid:pyridine:water (65:2:3:5:29)  (Boyle et al., 1991).  The positions 
of phosphoamino acid standards were determined by spraying with 0.25% 
ninhydrin dissolved in acetone. TLC plates were exposed to preflashed 
autoradiography film followed by densitometric analysis as above. Alter- 
natively, TLC plates were analyzed on a PhosphorImager (Molecular Dy- 
namics, Sunnyvale, CA) and densitometric measurements for each phos- 
phoamino acid achieved using ImageQuant-software (Molecular Dynamics). 
Both methods gave similar results and the data were pooled for further 
analysis. 
Fluorescence Recovery after Photobleaching 
Lateral mobility of fluorescently labeled AChRs was measured by the 
technique of fluorescence recovery after photobleaching, as first described 
by Axelrod et al. (1976). C2 myotube cultures were labeled with rhodamine- 
conjugated tx-bungarotoxin as  described  and rinsed several times with 
Puck's saline G  (Puck et al., 1958)  supplemented with 1.1 g/l glucose. To 
estimate changes in overall mobility of surface proteins, myotubes were 
labeled  with  10  i~g/ml  rhodamine-eonjugated succinyl-Con A  (sConA; 
Vector Labs, Burlingame, CA) for 15 rain at room temperature; condi- 
tions were chosen to maximiTg labeling while minimizing sConA-ind~ 
patching of surface proteins. Experiments were carded out at room tem- 
perature within 2 h of the last wash using a MRC 600 laser eonfocal micro- 
scope (Bio-Rad Laboratories, Hercules, CA) equipped with a  krypton- 
argon laser light source and a 40x water immersion objective. A  circular 
spot with a diameter of ,-,2 p,m was bleached by attenuating the beam to 
10% of its nominal energy by means of neutral density filters and focusing 
on a preselected location for three seconds. For experiments on nonaggre- 
gated AChRs and sConA-labeled surface proteins, images were obtained 
by scanning the field with the beam attenuated to the same extent. For ex- 
periments on aggregated AChRs, the beam was attenuated to 3% while 
images were acquired. Images were obtained immediately before bleach- 
ing, just after bleaching, after a 3-min recovery period, and, for sConA- 
labeled proteins, after 6 rain. The recovery periods were chosen to provide 
sufficient time for the more rapidly diffusing fraction of receptors and 
sConA-labeled proteins to equilibrate (Axelrod et al., 1976; Koppel et al., 
1976; Dubinsky et al., 1989). The images were digitized, aligned, and ana- 
lyzed using WHIP Virtual Image Processing Software (G. W. Hannaway 
and Associates, Boulder, CO). The average pixel intensity within the area 
bleached was determined for each frame, and the values corrected  for 
background pixel intensity. Bleaching resulted, on average, in a 56% de- 
crease in fluorescence. Recovery is expressed as a percent of the differ- 
ence in average pixel intensity before and immediately after the bleach. 
This simplified protocol did not allow determination of apparent diffusion 
constants, but did provide a measure of the proportion of AChRs free to 
diffuse laterally in the plane of the membrane. 
Detergent Extraction of  A ChRs 
Cultures were  incubated for  1 h  with 2  x  10 -s M  [125I]c~-bungarotoxin 
(Amersham) to label surface AChRs, and then rinsed twice with DME- 
F12 medium at room temperature, twice with ice cold Prives buffer A 
(Prives et al., 1982),  and extracted with ice cold Prives buffer A  supple- 
mented with 0.05% Triton X-100, 5 i~g/ml aprotinin, 5 i~g/ml leupeptin, 
100  ixM phenylmethylsulfonyl fluoride and 100 ixM sodium pervanadate 
(to inhibit tyrosine phosphatases during the prolonged extraction). The 
dishes were  gently agitated  on  a  cold  block  and  detergent-containing 
buffer was replaced at 5-min intervals. Residual AChRs were extracted 
into 1 N NaOH at the end of each experiment. Fractions were analyzed by 
gamma counting and the percent of AChRs remaining associated with the 
myotube cytoskeletons at each time point calculated, after correcting for 
nonspecific binding as determined from cultures labeled in the presence of 
a 50-fold excess of noniodinated a-bungarotoxin. 
To examine the relationship between AChR phosphorylation and de- 
tergent extractability, sister cultures were labeled with either [125I]a-bun- 
garotoxin or with biotin-a-bungarotoxin and [32p]orthophosphate as de- 
scribed above. Cultures were rinsed and extracted for 30 min on ice with 
Prives buffer A containing 0.05% Triton X-100, 5 p,g/ml aprotinin, 5 ixg/ml 
leupeptin,  100  p,M phenylmethylsulfonyl fluoride, and 100  p.M sodium 
pervanadate. Residual AChRs were solub'dized by 10 min incubation with 
extraction buffer containing 1%  Triton X-100, see above. These condi- 
tions were chosen so that each fraction (extracted  and residual)  contained 
approximately the same number of AChRs, as determined from cultures 
labeled with  [lz~I]ct-bungarotoxin. AChRs in fractions from 32p-labeled 
cultures were isolated on streptavidin-conjugated agarose beads and ana- 
lyzed by SDS-PAGE and autoradiography. Densitometric scans of the au- 
toradiograms were quantified for each AChR subunit. 
Results 
Agrin Induces Domains of Tyrosine Phosphorylation 
To d~ermine  the  effect of agrin  on the  distribution  of 
phosphotyrosine-containing  proteins  in  mouse  C2  myo- 
tubes', myotube cultures were treated overnight with agrin 
and labeled with anti-phosphotyrosine  antibodies.  Control 
rnyotubes  had spontaneously occurring  accumulations  of 
Meier et al. Protein Tyrosine Phosphorylation Immobilizes AChRs  443 Figure 1.  Agrin induces  do- 
mains  of  increased  protein 
tyrosine phosphorylation.  Flu- 
orescence  micrographs  of 
control (a and b) and agrin- 
treated  myotubes (c and  d) 
labeled  with  rhodamine- 
conjugated  et-bungarotoxin 
(AChR) and anti-phosphoty- 
rosine  monocional  antibody 
PY20 and fluorescein-conju- 
gated secondary antibody (P- 
tyr). Control myotubes have 
many small patches that label 
for phosphotyrosine but not 
for AChRs and a few larger 
domains  composed of coex- 
tensive  aggregates  of  phos- 
photyrosine  and  AChRs. 
Agrin induces the formation of additional large domains that stain intensely for phosphotyrosine and AChRs. (e) The number of AChR 
or phosphotyrosine-containing (P-tyrosine) aggregates per myotube segment was determined for control (con) and agrin-treated (agrin) 
myotubes. Data is expressed as mean --- SEM, N = 3. Bar: (a-d), 15 ixm. 
phosphotyrosine-containing proteins  (Fig.  1).  Many such 
spontaneous  patches  were small  (<2  txm  2)  and were not 
sites of AChR accumulation, as indicated by a low level of 
labeling  with  rhodamine-et-bungarotoxin.  Control  myo- 
tubes also had a few larger patches at which both phospho- 
tyrosine-containing  proteins  and  AChRs  were  concen- 
trated. Treating cultures with agrin resulted in an increase 
in  the  number  of relatively  large  patches  labeling  with 
anti-phosphotyrosine  antibodies  (Fig.  1).  Such  patches 
also labeled  intensely with  rhodamine-conjugated  ct-bun- 
garotoxin.  Indeed,  all  AChR aggregates,  both  in  control 
and  agrin-treated  cultures,  stained  for  phosphotyrosine. 
Thus, agrin induced the formation of patches on C2 myo- 
tubes  at  which  phosphotyrosine-containing  proteins  and 
AChRs accumulated. 
Agrin Reduces the Lateral Mobility of  A ChRs 
Several lines of evidence indicate that in muscle cells non- 
aggregated AChRs are relatively free to diffuse laterally in 
the plane of the membrane while receptors within  aggre- 
gates are immobile (Froehner, 1993). To assess the lateral 
mobility of AChRs in  mouse  C2 myotubes, we  used  the 
technique  of fluorescence  recovery after  photobleaching 
(Axelrod  et  al.,  1976; Dubinsky et  al.,  1989).  AChRs on 
the myotube surface were labeled with rhodamine-conju- 
gated  et-bungarotoxin,  a  small  spot was illuminated  with 
intense light to bleach the rhodamine bound to receptors 
in that region, and the rate at which receptors bearing un- 
bleached  rhodamine-et-bungarotoxin  molecules  diffused 
into the bleached spot was estimated from the recovery of 
Figure 2.  Fluorescence  recovery after 
photobleaching  measurements  of 
AChR  lateral  mobility.  Fluorescence 
micrographs of agrin-treated  (a), con- 
trol  (b),  and  pervanadate-treated  (c) 
myotubes  before  (top row), immedi- 
ately after (middle row), and 3 min af- 
ter (bottom row) a  2.5-p~m diam spot 
was photobleached in an area devoid 
of AChR aggregates. Recovery of fluo- 
rescence  within  the  bleached  area  in 
control and agrin-treated myotubes in- 
dicates  that  many of the  AChRs  are 
free  to  diffuse  laterally  in  the  mem- 
brane; the lack of recovery in the per- 
vanadate-treated  myotube  demon- 
strates  that  AChRs  are  less  mobile. 
Bar, 25 Ixm. 
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rescence recovery 3 min after photobleaching for AChRs within 
aggregates (aggregated) and for diffusely distributed AChRs (dif- 
fuse) in control (con), agrin-, and pervanadate-treated (per) myo- 
tubes. For aggregated AChRs, data were pooled from spontane- 
ously occurring and agrin-induced aggregates. Data is mean  _+ 
SEM, the number of observations is given within the columns. 
*Differs significantly from control, p  <  0.05 (one-way ANOVA, 
Tukey-Kramer HSD test). 
phorylation, then other treatments that cause an increase 
in  protein  tyrosine  phosphorylation  might  also  lead  to 
AChR immobilization. One mechanism by which the level 
of protein tyrosine phosphorylation can be increased is to 
Figure 3. Aggregated AChRs are immobile. Fluorescence micro- 
graphs  of a  C2  myotube  showing  an  AChR  aggregate before 
(top), immediately after (middle), and 3 min after (bottom) a 2.5- 
i~m diam spot was photobleached. The lack of recovery of fluo- 
rescence within the bleached spot demonstrates that aggregated 
AChRs are immobile. Bar, 10 I~m. 
fluorescence.  As  expected,  when  measurements  were 
made on areas of the myotube surface where  there were 
no recognizable receptor aggregates, there was an obvious 
recovery  of  fluorescence  in  both  control  myotubes  and 
myotubes treated overnight with agrin, indicating that dif- 
fusely  distributed  receptors  were  mobile  in  both  cases 
(Fig. 2, a  and b; Fig. 4). There was little recovery of fluo- 
rescence,  however,  when  spots  within  spontaneous  or 
agrin-induced  aggregates  were  bleached,  indicating that 
aggregated AChRs were relatively immobile (Figs. 3  and 
4). Thus agrin treatment created domains in cultured myo- 
tubes where  tyrosine phosphorylation was increased and 
AChR mobility was reduced. 
Pervanadate Selectively Inhibits Protein 
Tyrosine Phosphatases 
If AChRs  become  immobilized in  agrin-induced special- 
izations because of the localized increase in tyrosine phos- 
Figure 5. Pervanadate specifically inhibits protein tyrosine phos- 
phatases.  (P-ser/P-thr)  Control  (con)  and  pervanadate-treated 
(per)  myotube cultures labeled with  [32p]orthophosphate were 
rinsed and extracted. The extracts were analyzed for radioactivity 
associated with total TCA-precipitable material. (P-tyr) Control 
and  pervanadate-treated cultures  were  extracted,  samples ap- 
plied to nitrocellulose, and probed with anti-phosphotyrosine an- 
tibodies. Pervanadate (1 h, 30  tJ.M) had no significant effect on 
TCA-precipitable counts, which measure levels of protein phos- 
phoserine and phosphothreonine, but increased phosphotyrosine 
content nearly 40-fold. Left ordinate applies to P-ser/P-thr, right 
ordinate to P-tyr. Data is mean _+ SEM; N =  5 for P-ser/P-thr; N = 
3 for P-tyr. 
Meier  et al. Protein  Tyrosine  Phosphorylation  Immobilizes  AChRs  445 Figure 6. Pervanadate has little effect on the overall lateral mobil- 
ity of surface proteins. Analysis of the extent of fluorescence re- 
covery 3 and 6 min after photobleaching spots on control (con) 
and pervanadate-treated (perv) myotubes labeled with rhodamine- 
conjugated  succinyl Concanavalin-A  (sConA).  The  extent  of 
recovery  was  similar in  both control  and  pervanadate-treated 
myotubes, indicating that pervanadate  did not have a significant 
effect  on  the  average  mobility  of surface  proteins  that  bind 
sConA. Data is expressed as mean -+ SEM, N = 30-39. 
prevent ongoing dephosphorylation by inhibiting tyrosine 
phosphatases. To determine the effect of inhibiting phos- 
phatases in C2 myotubes, cultures were treated with sodium 
pervanadate, a protein tyrosine phosphatase inhibitor (Pu- 
miglia et al., 1992) and changes in protein phosphorylation 
Figure 7. Effects of agrin and pervanadate  on the distribution of 
surface AChRs.  Fluorescence  micrographs of C2 myotubes  la- 
beled with rhodamine-c~-bungarotoxin  after incubation for 4 h in 
control medium (A), with agrin (B), or with agrin and 30 p~M so- 
dium pervanadate (C). Pervanadate had little effect on spontane- 
ously occurring AChR aggregates but prevented  agrin-induced 
AChR aggregation. Bar, 20 Ixm. 
Figure 8. Pervanadate inhibits agrin-induced AChR aggregation. 
C2 cultures were incubated in normal medium (normal), or me- 
dium containing 30 ~M sodium pervanadate  (pervanadate) and 
treated with (agrin) or without (con) agrin for 4 h. AChRs were 
visualized with rhodamine  a-bungarotoxin  and  the  number  of 
AChR aggregates per myotube counted.  Data is mean _+SEM, 
N=3. 
were  assayed. As illustrated  in Fig. 5, treating myotubes 
with pervanadate (30 p,M, 1 h) caused a large increase in 
their phosphotyrosine content, but no change in phospho- 
serine/phosphothreonine  content.  Thus,  pervanadate  se- 
lectively  inhibited  protein  tyrosine  phosphatases  in  C2 
myotubes. 
Pervanadate Induces Tyrosine Phosphorylation and 
A ChR Immobilization throughout Myotubes 
Pervanadate-treated myotubes stained more intensely with 
anti-phosphotyrosine antibodies, but the distribution of la- 
bel was indistinguishable from that in control cultures. Thus, 
pervanadate increased tyrosine phosphorylation through- 
out the myotubes. To determine the effects of this wide- 
spread increase in tyrosine phosphorylation on the mobility 
of surface AChRs, receptors were labeled with rhodamine 
a-bungarotoxin and their lateral mobility measured by flu- 
orescence recovery after photobleaching. As illustrated in 
Figs. 2 c and 4, in myotubes treated with 30 }xM pervana- 
date for 1 h the mobility of diffusely distributed  AChRs 
was  significantly lower than  in  control  myotubes. Thus, 
pervanadate caused a widespread increase in tyrosine phos- 
phorylation and  reduced  the  mobility of nonaggregated 
AChRs throughout the myotubes. 
To test  if pervanadate  was causing a  nonselective  de- 
crease in the mobility of surface proteins, myotubes were 
labeled with rhodamine-conjugated succinyl Concanavalin 
A  (sConA) and fluorescence recovery after photobleach- 
ing tested,  sConA binds to terminal a-D-mannosyl and 
o~-D-glucosyl residues, carbohydrates found on many sur- 
face proteins, and so can be used to measure the average 
mobility of a large subset of membrane proteins (Koppel 
et al., 1976). In control cultures, spots bleached in cells la- 
beled with rhodamine-conjugated sConA took somewhat 
longer to recover than did spots bleached in myotubes la- 
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date induce  phosphorylation 
of the AChR 13, % and 8 sub- 
units.  (left panel)  C2  myo- 
tube  cultures  were  labeled 
for 4 h  with  [32p]orthophos- 
phate  and  AChRs  were 
isolated  and  analyzed  by 
SDS-PAGE and autoradiog- 
raphy. Compared to control 
cultures  (con), addition  of 
agrin  (ag) or 30 p~M sodium 
pervanadate (per) during the 
4-h incubation  with  [32p]or- 
thophosphate increased phos- 
phorylation of the AChR 13, 
~, and ~ subunits.  Bands la- 
beled  as  13,  %  and  8  were 
identified  as AChR subunits 
because they were absent from samples in which the isolation of AChRs was specifically blocked by including an excess of unconjugated 
a-bungarotoxin during incubation  with biotin-conjugated  toxin (blk). (anti-/J) Western blot of C2 AChRs probed with anti-13 subunit 
monoclonal antibody (mAb 148). The position of prestained molecular weight markers is shown on the left. (right  panels) Quantitative 
analysis of agrin- and pervanadate-induced changes in AChR subunit  phosphorylation.  The level of incorporation of [32p]orthophos- 
phate into AChR subunits was measured by densitometric analysis of autoradiograms; data from different experiments were combined 
by normalizing the results to the 8 subunit of control myotubes in normal medium (= 1,000). Both agrin (ag) and pervanadate (perv) sig- 
nificantly increased phosphorylation of the 13, % and 8 subunits. Data is mean --- SEM, N = 18 for control, 27 for agrin, and 7 for pervan- 
adate. * Differs significantly from control cultures, Ildiffers  significantly from agrin-treated cultures, p < 0.05 (one-way ANOVA, Tukey- 
Kramer HSD test). 
beled  with  rhodamine-conjugated  ot-bungarotoxin,  indi- 
cating that the lateral mobility of sConA-binding proteins 
was on average less than  that  of AChRs  (Koppel et  al., 
1976). Pervanadate (30 IxM, 1 h) had little or no effect on 
the  lateral  mobility of sConA-binding  proteins  (Fig.  6). 
Thus, pervanadate-induced AChR immobilization was se- 
lective and not the result of a general decrease in the mo- 
bility of surface proteins. 
Pervanadate Prevents Agrin-induced 
A ChR Aggregation 
Agrin-induced  AChR  aggregation  occurs  by  the  lateral 
migration of AChRs  already in  the  myotube membrane 
(Godfrey et al., 1984; Wallace, 1988). If pervanadate causes 
AChR immobilization, this would be expected to prevent 
agrin-induced AChR aggregation. As illustrated in Figs. 7 
and  8,  pervanadate  completely  inhibited  agrin-induced 
AChR  aggregation,  consistent  with the  finding  that  per- 
vanadate  reduced  the  mobility  of  diffusely  distributed 
AChRs. 
Agrin and Pervanadate Induce A ChR 
Tyrosine Phosphorylation 
As a step toward determining how increased tyrosine phos- 
phorylation  might  cause  AChR  immobilization,  we  ex- 
amined  the  effects  of  agrin  and  pervanadate  on  AChR 
phosphorylation. Treating myotubes with agrin caused a sig- 
nificant  increase  in  phosphorylation of the  AChR  13,  % 
and 8 subunits (Fig. 9). Similar increases were observed by 
phosphoamino acid analysis of isolated receptor subunits, 
although the only agrin-induced change that was statisti- 
cally significant by this analysis was an increase in tyrosine 
phosphorylation of the AChR 13 subunit (Table I). Pervan- 
adate also caused a significant increase in AChR phosphor- 
ylation (Fig. 9), including tyrosine phosphorylation of the 
AChR  13 subunit  (Table I). In addition,  pervanadate in- 
creased  tyrosine  phosphorylation  of the  AChR  ~/  and  8 
subunits (Table I) and of a large number of other proteins 
(data not shown, see Wallace, 1995).  Thus, both agrin and 
pervanadate caused an increase in  AChR tyrosine phos- 
phorylation. 
Table L Effects of  Agrin and Pervanadate on AChR Phosphoamino Acid Content 
Control  Agrin  ~  Pervanadate 
Subunit  P-ser*  P-tyr  P-ser  P-tyr  P-ser  P-tyr 
13  140 --  19  123  --  19  175  --  19  388  -- 448  233  ±  29  755  --  175 §11 
~/  342 ±  30  172  ±  25  361  ±  41  215  -- 22  410 ±  72  309  -- 43 § 
708  +  26  292  ±  23  714  -- 77  390  ±  51  1070 ±  205 II  714  -- 75 ~11 
(10)  (13)  (5) 
Data expressed as mean _+ SEM, number of observations in parentheses. 
*Total phosphoamino acid content determined from autoradiogram densities normalized such that phosphoserine (P-ser) + phosphotyrosine (P-tyr)  content = 1000 for 8 subunit 
of control myotubes. 
*Experiments with 4- and 16-h agrin treatment pooled. 
§Differs significantly from control (one-way ANOVA, Tukey-Kramer HSD test, p  <  0.05). 
IIDiffers significantly from agrin (one-way ANOVA, Tukey-Kramer HSD test, p  <  0.05). 
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ability  of surface AChRs. (a) Control, agrin-,  and pervanadate- 
treated C2 cultures were incubated with [125I]a-bungarotoxin  to 
label surface AChRs, rinsed, and extracted with buffer contain- 
ing 0.05% Triton X-100. The percent of receptors remaining as- 
sociated with the myotube cytoskeletons is plotted as a function 
of time  of extraction  for triplicate  cultures  (Data  is  mean  -+ 
SEM, N =  3; error bars are shown where they exceed the size of 
the data point). (b) Summary of results from seven experiments 
on control (con), agrin- (agrin), and pervanadate-treated (perv) 
cultures.  For each culture, the rate Of AChR extraction was de- 
termined  by least  squares 'fit  to the  5-,  10-,  and  15-min  time 
points, and then normalized to the slope observed under control 
conditions (= 1.0) in the same experiment. Data is expressed as 
mean -  SEM, N  =  21. *Differs  significantly  from control, **dif- 
fers significantly from control and from agrin, p  <  0.05 (one-way 
ANOVA, Tukey-Kramer HSD test). 
Agrin and Pervanadate Decrease A ChR 
Detergent Extractability 
If AChR phosphorylation caused the decrease in receptor 
mobility, then only immobilized receptors would be phos- 
phorylated. Unfortunately, we could not determine if this 
was  the  case  by  the  fluorescence  recovery  after  pho- 
tobleaching  technique.  However,  results  of previous  ex- 
periments  (Prives  et  al.,  1982;  Stya  and  Axelrod,  1983; 
Podleski and Salpeter,  1988) suggest that immobile recep- 
tors  are  relatively  resistant  to  detergent  extraction.  Ac- 
cordingly, we sought to compare the detergent extractabil- 
ity of phosphorylated and nonphosphorylated AChRs. 
We first examined the effects of agrin and pervanadate 
on the overall detergent extractability of AChRs. Treating 
myotubes for 4 h with agrin reduced the rate of detergent 
extraction  of AChRs  by ~12%;  treating  myotubes with 
pervanadate for 1 h caused a 25% decrease (Fig. 10). Thus, 
both  agrin  and pervanadate  decreased  the  rate  at which 
AChRs were extracted from intact myotubes by mild de- 
tergent treatment. 
To determine  if phosphorylated AChRs were extracted 
more slowly than nonphosphorylated receptors, myotubes 
were incubated with agrin and [32p]orthophosphate for 4 h, 
and  then  extracted  for  30  min  with  buffer  containing 
0.05%  Triton X-100, removing approximately  half of the 
AChRs.  Subsequently,  residual  AChRs  were  solubilized 
in buffer containing  1%  Triton X-100. Extracted  and re- 
sidual AChRs were isolated and analyzed by SDS-PAGE 
and autoradiography. The number of AChRs in each frac- 
tion was determined by measuring the appearance of [125I] 
Figure 11.  Phosphorylated  AChRs  are  extracted  from  agrin- 
treated myotubes more slowly than nonphosphorylated AChRs. 
C2 myotube cultures were incubated with agrin and [32p]ortho- 
phosphate for 4 h  and extracted for 30 min with 0.05%  Triton 
X-100.  (left panel) Autoradiogram of AChRs extracted  during 
detergent treatment (ext) and the residual AChRs remaining as- 
sociated with the myotube cytoskeletons (res). The fraction of 
AChRs in the samples, determined from parallel extractions of 
[125I]ct-bungarotoxin-labeled  cultures, was 39%  extracted,  61% 
residual.  (right panel) The relative specific  activity of extracted 
(ext) and  residual  (res) AChR subunits  was  determined  from 
densitometric analysis  of AChRs in extracts of 32p-labeled  cul- 
tures and quantitation  of AChRs in parallel extracts of [125I]et- 
bungarotoxin-labeled cultures. If phosphorylated and nonphos- 
phorylated  AChRs  had  similar  detergent  extractabilities,  the 
relative specific activity  would be one for both extracted and re- 
sidual receptors (dotted line). Data is expressed as mean _+ SEM, 
N =  10. For each subunit, the specific activity of residual AChRs 
differs significantly  from that of extracted AChRs, p <  0.05 (one- 
way ANOVA, Tukey-Kramer HSD test). 
in  corresponding  extracts  of sister  cultures  labeled  with 
[125I]ot-bungarotoxin. As shown in Fig. 11, in agrin-treated 
cultures  AChRs  extracted  during  30  min  of incubation 
with  0.05%  Triton  were  predominately  nonphosphory- 
lated; phosphorylated AChRs tended to remain associated 
with  the  myotube cytoskeleton.  The  results  were  similar 
for [3, %  and ~ subunits.  Thus, in agrin-treated  myotubes 
phosphorylated AChRs were relatively resistant to deter- 
gent extraction compared to nonphosphorylated receptors. 
Tyrosine Phosphorylation at Developing 
Neuromuscular  Junctions In Vivo 
There is considerable evidence that agrin mediates AChR 
aggregation  at  developing  synapses  (McMahan,  1990; 
Reist et al.,  1992; Hall and Sanes,  1993). Accordingly, we 
sought  to  determine  if AChR  aggregates  at  developing 
synapses corresponded to sites of increased tyrosine phos- 
phorylation. As illustrated in Fig. 12, anti-phosphotyrosine 
monoclonal antibody PY20 labeled developing neuromus- 
cular junctions in rat diaphragm as early as embryonic day 
18  (the  earliest  time  yet  examined).  The  labeling  was 
blocked by 0.2 mM phosphotyrosine, but not by phospho- 
serine  or  phosphothreonine,  indicating  that  the  binding 
was specific.  Similar  results  were obtained with  a  second 
anti-phosphotyrosine  monoclonal  antibody,  4G10.  Thus, 
in  rodent  muscle  cells  both nerve-  and  agrin-induced  in- 
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phosphotyrosine antibody. Fluorescence micrographs of two end- 
plates  in  an El8 rat diaphragm  in whole  mount labeled  with 
rhodamine-conjugated  et-bungarotoxin to visualize the distribu- 
tion of AChRs  (a) and anti-phosphotyrosine  monoclonal  anti- 
body PY20 and fluorescein-conjugated  secondary  antibody (b). 
Bar, 20 p.m. 
creases in tyrosine phosphorylation appear to occur early 
enough to mediate AChR aggregation. 
Discussion 
The results reported here demonstrate that agrin induces 
the formation of patches in cultured C2 myotubes at which 
phosphotyrosine-containing proteins and AChRs accumu- 
late. Within these patches AChRs are relatively immobile, 
as judged by fluorescence recovery after photobleaching 
measurements. Treating myotubes with the tyrosine phos- 
phatase  inhibitor pervanadate  caused  an  increase  in  ty- 
rosine phosphorylation and a decrease in the mobility of 
AChRs throughout the myotube. Both agrin and pervana- 
date caused an increase in tyrosine phosphorylation of the 
AChR  [3 subunit.  Phosphorylated AChRs were less rap- 
idly  extracted  from  intact  myotubes  by  mild  detergent 
treatment than were nonphosphorylated receptors. Sites 
of AChR  aggregation in  developing rat muscles also la- 
beled with anti-phosphotyrosine antibodies. We conclude 
that both in vitro and in vivo agrin induces the formation 
of domains of increased protein tyrosine phosphorylation 
in myotubes within which AChRs become phosphorylated 
and immobilized. 
Lateral Mobility of  A ChRs 
In  the experiments reported here, AChRs  within aggre- 
gates were found to be relatively immobile, as expected. 
On the other hand, diffusely distributed AChRs in both 
control and agrin-treated C2 myotubes appeared equally 
mobile. This observation differs somewhat from results of 
experiments in which an extract of Torpedo electric organ 
was found to restrict partially the mobility of a portion of 
the diffusely distributed AChRs  in chick myotubes (Du- 
binsky et al., 1989). The reason for this discrepancy is un- 
clear. First, although the extract used in the earlier experi- 
ments  probably contained agrin,  there might  have been 
additional  factors present  that  affected AChR  mobility. 
Second, the overall density of AChRs is considerably higher 
on mouse C2 cells than on chick myotubes, and a large num- 
ber  of freely diffusing receptors might  obscure  a  small 
population of AChRs whose mobility is partially restricted. 
Alternatively, the discrepancy might reflect differences in 
when  during agrin treatment  and  where with respect to 
emerging aggregates receptor mobility measurements were 
made, :Clearly, more detailed information concerning the 
time course of agrin-induced changes in phosphorylation, 
AChR  aggregation,  and  receptor mobility in  mouse  C2 
myotubes is required. 
Pervanadate caused a significant reduction in the aver- 
age lateral mobility of diffusely distributed receptors. This 
effect may account for the ability of pervanadate to inhibit 
agrin-induced AChR aggregation, which normally occurs 
by lateral migration (Godfrey et al., 1984; Wallace, 1988). 
Pervanadate did not reduce the mobility of diffusely dis- 
tributed AChRs to the same extent as seen for receptors 
within aggregates. This might reflect the proportion of re- 
ceptors phosphorylated in each location. Alternatively, ty- 
rosine phosphorylation of components in addition to AChRs 
might contribute to AChR  immobilization within aggre- 
gates. This could account for the observation that at adult 
rat neuromuscular junctions denervation leads to a rapid 
reduction in tyrosine phosphorylation of the AChR 13 sub- 
unit  but  relatively little  change  in  receptor aggregation 
(Qu et al., 1990).  Indeed, we have found that both agrin 
and pervanadate induce increased phosphorylation of sev- 
eral  components  of  the  dystrophin/utrophin  complex 
(Meier, T., and B. G. Wallace, manuscript in preparation). 
It has been suggested that components of the dystrophin 
complex might play a role in AChR aggregation (Kramarcy 
et al., 1994). 
Distribution of  Protein Tyrosine Kinases and 
Phosphatases Regulating A ChR Phosphorylation 
and Mobility 
The fact that pervanadate treatment caused phosphoryla- 
tion and reduced the mobility of receptors throughout C2 
myotubes  suggests  that  there  are  diffusely  distributed, 
spontaneously active protein tyrosine kinases  and  phos- 
phatases catalyzing ongoing phosphorylation and dephos- 
phorylation of AChRs. The lack of effect of agrin on the 
mobility of nonaggregated AChRs is consistent with the 
hypothesis that interaction of agrin with its receptor cre- 
ates circumscribed domains of increased protein tyrosine 
phosphorylation that correspond to the dimensions of re- 
ceptor aggregates. The identities of the agrin receptor and 
the protein tyrosine kinases and phosphatases that regu- 
late AChR phosphorylation in muscle cells have yet to be 
determined.  One  of the  components  of the  dystrophin- 
associated  protein  complex,  et-dystroglycan,  appears  to 
comprise at least part of a receptor for agrin (Bowe et al., 
1994; Gee et al., 1994; Campanelli et al., 1994; Sugiyama et 
al., 1994; Cohen et al., 1995), but it is not clear if binding of 
agrin to et-dystroglycan mediates AChR aggregation (Su- 
giyama et al., 1994).  AChRs isolated from Torpedo elec- 
tric organ postsynaptic membranes have associated with 
them two src-like protein tyrosine kinases capable of phos- 
phorylating  the  AChR  13  subunit  (Swope  and  Huganir, 
1993).  A  protein tyrosine phosphatase that dephosphory- 
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organ (Mei and Huganir, 1991). Whether these or similar 
enzymes play a  role in AChR aggregation in muscle re- 
mains to be determined. 
A ChR Phosphorylation and Interaction 
with the Cytoskeleton 
In previous experiments on chick myotubes changes in ty- 
rosine phosphorylation of the AChR [3 subunit were cor- 
related  with  changes  in  AChR  detergent  extractability 
(Wallace, 1992, 1994, 1995). Likewise, in mouse C2 myo- 
tubes both agrin and pervanadate increased tyrosine phos- 
phorylation of the AChR [3 subunit and decreased deter- 
gent extractability of AChRs. Indeed, compared to agrin, 
pervanadate caused a 2-34old greater increase in [3-sub- 
unit tyrosine phosphorylation and a  twofold greater de- 
crease in the rate of detergent extraction. 
The decrease in the rate of detergent extractability was 
not large, although it was very reproducible. This might in- 
dicate that only a small fraction of all AChRs  are phos- 
phorylated, even in pervanadate-treated myotubes. Alter- 
natively,  the  composition  of  the  detergent  treatment 
buffer might not be appropriate for maintaining interac- 
tions between the receptor and the underlying cytoskeleton. 
If phosphorylation of AChRs  caused  the  decrease in 
their detergent extractability, then phosphorylated recep- 
tors would be extracted more slowly than nonphosphory- 
lated receptors. Analysis of the extent of phosphorylation 
of AChRs  released  during  detergent  treatment  demon- 
strated that in agrin-treated C2 myotubes phosphorylated 
AChRs  were indeed more resistant to detergent extrac- 
tion  than  nonphosphorylated  AChRs.  However,  if  ty- 
rosine phosphorylation of the AChR [3 subunit were the 
sole  determinant of the  rate  of detergent extraction, as 
suggested by our previous results in chick myotubes, then 
one might  expect that phosphorylated ~/  and  5  subunits 
would be evenly distributed among more rapidly and more 
slowly extracted AChRs.  This was not the case, AChRs 
bearing phosphorylated "y and 8 subunits were also rela- 
tively resistant to detergent extraction. One explanation 
for this finding might be that phosphorylation of any sub- 
unit slows the rate of detergent extraction. This does not 
appear to be the case in chick myotubes, however, where 
in  the  presence of the  protein tyrosine kinase  inhibitor 
staurosporine agrin induces phosphorylation of the AChR 
~/and 5 subunits, but does not reduce the rate of AChR 
detergent extraction (Wallace, 1994). A second possibility 
is that phosphorylation of the various subunits might not 
be mutually independent. For example, agrin might pref- 
erentially induce tyrosine phosphorylation of the  [3 sub- 
unit of receptors that are already phosphorylated on the "y 
and 5 subunits. Alternatively, agrin might create domains 
of increased tyrosine kinase activity within which AChRs 
become attached to the cytoskeleton and immobilized by a 
mechanism  that  does  not  rely  on  phosphorylation  of 
AChRs but on phosphorylation of other membrane or cy- 
toskeletal proteins, such as components of the dystrophin 
complex. Under such circumstances, AChRs more slowly 
extracted by detergent treatment might be preferentially 
phosphorylated simply as a consequence of their location 
within such a domain. 
Tyrosine Phosphorylation at Developing Synapses 
We report here that AChR aggregates at developing neu- 
romuscular junctions  in  embryonic rat  diaphragm  label 
with anti-phosphotyrosine antibodies, as would be expected 
if tyrosine phosphorylation mediates AChR aggregation. 
No labeling was seen in the absence of primary antibody 
or when 0.2 mM phosphotyrosine (but not phosphoserine 
or  phosphothreonine)  was  included  during  incubation 
with the primary antibody, indicating that the labeling was 
specific for phosphotyrosine. This result stands in contrast 
to a previous report that AChR aggregates at neuromus- 
cular junctions in embryonic and neonatal rat diaphragm 
do not label with anti-phosphotyrosine antibodies (Qu et 
al., 1990). The reason for this discrepancy is not clear. Per- 
haps  the  methods used  in the present study were more 
sensitive than those used in the earlier report. For exam- 
ple, Qu et al. (1990) incubated permeabilized whole mounts 
of neonatal diaphragm for only 30 min in primary anti- 
body diluted  in  phosphate  buffered saline,  whereas  we 
routinely incubated tissue for 1 h in primary antibody di- 
luted in Tris buffered saline. 
The data presented in this report demonstrate that agrin 
induces tyrosine phosphorylation and  immobilization of 
AChRs in mouse C2 myotubes. We also demonstrate that 
sites of AChR aggregation in rodent myotubes in vivo and 
in vitro label with anti-phosphotyrosine antibodies. While 
it is tempting to conclude that such staining is due to phos- 
phorylated receptors, it seems likely that other phosphoty- 
rosine-containing proteins contribute. For example, in Xe- 
nopus myocytes sites at which AChRs will accumulate can 
be visualized with anti-phosphotyrosine antibodies before 
they can be detected with rhodamine-conjugated et-bunga- 
rotoxin (Baker and Peng, 1993). To understand the role of 
tyrosine phosphorylation in postsynaptic differentiation, it 
will be important to determine directly when during em- 
bryonic development in vivo AChRs and other postsynap- 
tic proteins become phosphorylated and if such phospho- 
rylated proteins are localized at neuromuscular junctions. 
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